You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

MECLIZINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for meclizine hydrochloride and what is the scope of patent protection?

Meclizine hydrochloride is the generic ingredient in two branded drugs marketed by Casper Pharma Llc, Invagen Pharms, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms, Apnar Pharma Lp, Aurobindo Pharma Usa, Bundy, Chartwell Rx, Epic Pharma Llc, Invatech, Jubilant Cadista, Kv Pharm, Rising, Sandoz, Strides Pharma, Superpharm, UDL, Vangard, Watson Labs, and Zydus Lifesciences, and is included in thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for meclizine hydrochloride. Thirty-three suppliers are listed for this compound.

Summary for MECLIZINE HYDROCHLORIDE
US Patents:0
Tradenames:2
Applicants:25
NDAs:38
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 33
Raw Ingredient (Bulk) Api Vendors: 182
Clinical Trials: 10
Patent Applications: 6,780
What excipients (inactive ingredients) are in MECLIZINE HYDROCHLORIDE?MECLIZINE HYDROCHLORIDE excipients list
DailyMed Link:MECLIZINE HYDROCHLORIDE at DailyMed
Recent Clinical Trials for MECLIZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mansoura UniversityPhase 1/Phase 2
Hospital Federal de BonsucessoPhase 4
Tannaz ArmaghanyPhase 1

See all MECLIZINE HYDROCHLORIDE clinical trials

Pharmacology for MECLIZINE HYDROCHLORIDE
Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Medical Subject Heading (MeSH) Categories for MECLIZINE HYDROCHLORIDE

US Patents and Regulatory Information for MECLIZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abc Holding MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085252-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Kv Pharm MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085523-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Kv Pharm MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085524-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.